2. Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol 2023;79:516-537.
6. Bavarsad K, Riahi MM, Saadat S, Barreto G, Atkin SL, Sahebkar A. Protective effects of curcumin against ischemiareperfusion injury in the liver. Pharmacol Res 2019;141:53-62.
7. Pantazi E, Bejaoui M, Folch-Puy E, Adam R, Roselló-Catafau J. Advances in treatment strategies for ischemia reperfusion injury. Expert Opin Pharmacother 2016;17:169-179.
8. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003;125:1246-1257.
9. Peralta C, Jiménez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol 2013;59:1094-1106.
12. Liu H, Man K. New insights in mechanisms and therapeutics for short- and long-term impacts of hepatic ischemia reperfusion injury post liver transplantation. Int J Mol Sci 2021;22:8210.
14. Schusdziarra C, Blamowska M, Azem A, Hell K. Methylationcontrolled J-protein MCJ acts in the import of proteins into human mitochondria. Hum Mol Genet 2013;22:1348-1357.
18. Zeng H, Saari JT, Johnson WT. Copper deficiency decreases complex IV but not complex I, II, III, or V in the mitochondrial respiratory chain in rat heart. J Nutr 2007;137:14-18.
19. Zhuang R, Chen M, Zhou Y, Cheng W, Zhang T, Ni Y, et al. Virus-mimicking liposomal system based on dendritic lipopeptides for efficient prevention ischemia/reperfusion injury in the mouse liver. ACS Macro Lett 2021;10:215-222.
20. Frye RA. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun 1999;260:273-279.
36. Hide D, Warren A, Fernández-Iglesias A, Maeso-Díaz R, Peralta C, Le Couteur DG, et al. Ischemia/reperfusion injury in the aged liver: The importance of the sinusoidal endothelium in developing therapeutic strategies for the elderly. J Gerontol A Biol Sci Med Sci 2020;75:268-277.
38. Anavi S, Tirosh O. iNOS as a metabolic enzyme under stress conditions. Free Radic Biol Med 2020;146:16-35.
40. Shen Y, Shen X, Cheng Y, Liu Y. Myricitrin pretreatment ameliorates mouse liver ischemia reperfusion injury. Int Immunopharmacol 2020;89:107005.
42. Li Z, Wang Y, Zhang Y, Wang X, Gao B, Li Y, et al. Protective effects of fisetin on hepatic ischemia-reperfusion injury through alleviation of apoptosis and oxidative stress. Arch Med Res 2021;52:163-173.
44. Yu Q, Chen S, Tang H, Zhang X, Tao R, Yan Z, et al. Veratric acid alleviates liver ischemia/reperfusion injury by activating the Nrf2 signaling pathway. Int Immunopharmacol 2021;101:108294.
47. Yuan B, Huang H, Qu S, Zhang H, Lin J, Jin L, et al. Gastrodin pretreatment protects liver against ischemia-reperfusion injury via activation of the Nrf2/HO-1 pathway. Am J Chin Med 2020;48:1159-1178.
54. Wang Q, Zhou H, Bu Q, Wei S, Li L, Zhou J, et al. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis. J Hepatol 2022;77:312-325.
56. Saleh H, El-Shorbagy HM. Chitosan protects liver against ischemia-reperfusion injury via regulating Bcl-2/Bax, TNF-α and TGF-β expression. Int J Biol Macromol 2020;164:1565-1574.
58. Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND, et al. New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact 2018;292:76-83.
59. Yang Y, Liu R, Qu Y, Zhao J, Tong L, Ye S, et al. Ghrelin ameliorates transformation of hepatic ischemia-reperfusion injury to liver fibrosis by blocking Smad and ERK signalling pathways, and promoting anti-inflammation and anti-oxidation effects. Transpl Immunol 2022;73:101597.
62. Zhu S, Wang X, Chen H, Zhu W, Li X, Cui R, et al. Hippo (YAP)-autophagy axis protects against hepatic ischemiareperfusion injury through JNK signaling. Chin Med J (Engl) 2024;137:657-668.
70. Li Y, Gao M, Xu LN, Yin LH, Qi Y, Peng JY. MicroRNA-142-3p attenuates hepatic ischemia/reperfusion injury via targeting of myristoylated alanine-rich C-kinase substrate. Pharmacol Res 2020;156:104783.
71. Wang M, Zhang J, Zhang J, Sun K, Li Q, Kuang B, et al. Methyl eugenol attenuates liver ischemia reperfusion injury via activating PI3K/Akt signaling. Int Immunopharmacol 2021;99:108023.
73. Kim HJ, Joe Y, Yu JK, Chen Y, Jeong SO, Mani N, et al. Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway. Biochim Biophys Acta 2015;1852:1550-1559.
77. Kadono K, Kageyama S, Nakamura K, Hirao H, Ito T, Kojima H, et al. Myeloid Ikaros-SIRT1 signaling axis regulates hepatic inflammation and pyroptosis in ischemia-stressed mouse and human liver. J Hepatol 2022;76:896-909.
83. Zhang Y, Jia K, Li Y, Ma Z, Fan G, Luo R, et al. Radix Rehmanniae Praeparata aqueous extract improves hepatic ischemia/reperfusion injury by restoring intracellular iron homeostasis. Chin J Nat Med 2023;21:1-17.
86. Ma T, Zhang H, Li T, Bai J, Wu Z, Cai T, et al. Protective effect of pinocembrin from Penthorum chinense Pursh on hepatic ischemia reperfusion injury via regulating HMGB1/TLR4 signal pathway. Phytother Res 2023;37:181-194.
95. Gendy AM, Elnagar MR, Allam MM, Mousa MR, Khodir AE, El-Haddad AE, et al. Berberine-loaded nanostructured lipid carriers mitigate warm hepatic ischemia/reperfusion-induced lesion through modulation of HMGB1/TLR4/NF-κB signaling and autophagy. Biomed Pharmacother 2022;145:112122.
101. Li S, Fan G, Li X, Cai Y, Liu R. Modulation of type I interferon signaling by natural products in the treatment of immunerelated diseases. Chin J Nat Med 2023;21:3-18.
102. Li Y, Ma Z, Ding M, Jia K, Xu B, Zhou F, et al. Chuanxiong Rhizoma extracts prevent cholestatic liver injury by targeting H3K9ac-mediated and cholangiocyte-derived secretory protein PAI-1 and FN. Chin J Nat Med 2023;21:694-709.
104. Morsy MA, Abdel-Gaber SA, Rifaai RA, Mohammed MM, Nair AB, Abdelzaher WY. Protective mechanisms of telmisartan against hepatic ischemia/reperfusion injury in rats may involve PPARγ-induced TLR4/NF-κB suppression. Biomed Pharmacother 2022;145:112374.
106. Gendy A, Elnagar MR, Soubh A, Al-Mokaddem A, El-Haddad A, El-Sayed MK. Morin alleviates hepatic ischemia/reperfusion-induced mischief: In vivo and in silico contribution of Nrf2, TLR4, and NLRP3. Biomed Pharmacother 2021;138:111539.
112. Shi G, Zhang Z, Ma S, Li Y, Du S, Chu Y, et al. Hepatic interferon regulatory factor 8 expression mediates liver ischemia/reperfusion injury in mice. Biochem Pharmacol 2021;192:114728.
118. Stephan A, Fabri M. The NET, the trap and the pathogen: neutrophil extracellular traps in cutaneous immunity. Exp Dermatol 2015;24:161-166.
120. Wang Y, Sun X, Han X, Sun J, Li L, Zhang D, et al. Resveratrol improves hepatic ischemia-reperfusion injury by inhibiting neutrophils via the ERK signaling pathway. Biomed Pharmacother 2023;160:114358.
126. Wang YY, Diao BZ, Zhong LH, Lu BL, Cheng Y, Yu L, et al. Maslinic acid protects against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice. Microb Pathog 2018;119:49-53.
130. Nakamoto S, Ito Y, Nishizawa N, Goto T, Kojo K, Kumamoto Y, et al. Lymphangiogenesis and accumulation of reparative macrophages contribute to liver repair after hepatic ischemiareperfusion injury. Angiogenesis 2020;23:395-410.
141. Kojima H, Kadono K, Hirao H, Dery KJ, Torgerson T, Yao S, et al. T Cell CEACAM1-TIM-3 crosstalk alleviates liver transplant injury in mice and humans. Gastroenterology 2023;165:1233-1248 e9.
147. Yu S, Liu X, Xu Y, Pan L, Zhang Y, Li Y, et al. m6A-mediated gluconeogenic enzyme PCK1 upregulation protects against hepatic ischemia-reperfusion injury. Hepatology 2023 Dec 12;doi: 10.1097/HEP.0000000000000716.
148. Dong J, Ke MY, Wu XN, Ding HF, Zhang LN, Ma F, et al. SRY is a key mediator of sexual dimorphism in hepatic ischemia/reperfusion injury. Ann Surg 2022;276:345-356.